Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi eyes 40 pct of sales from emerging mkts -CEO
Reuters
Fri, 03/30/12 - 11:00 am
Tags:
Sanofi, emerging markets, Pharma CEOs, Chris Viehbacher
How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thu, 03/29/12 - 05:19 pm
Tags:
Biomarin, Amicus Therapeutics, Sanofi, Vertex
Abbott: Expect Strong Upside Movement, Both Pre And Post Research Division Spin-Off
Seeking Alpha
Thu, 03/29/12 - 11:58 am
Tags:
Abbott Laboratories, JNJ, Merck, Pfizer, Sanofi, Watson Pharmaceuticals
Large Market Opportunity Emerges For Oculus Technology
Seeking Alpha
Wed, 03/28/12 - 10:19 am
Tags:
Oculus, GSK, JNJ, Novartis, Sanofi, Vivus
Regeneron cholesterol drug faces sudden challenge
Reuters
Mon, 03/26/12 - 12:10 pm
Tags:
Amgen, Regeneron, PCSK9 inhibitor, AMG145, REGN727, Sanofi
Sanofi to Acquire Pluromed
Yahoo/Zacks
Sat, 03/24/12 - 11:34 am
Tags:
Sanofi, Pluromed
Sanofi: A Good Long-Term Dividend Play?
Seeking Alpha
Fri, 03/23/12 - 12:42 pm
Tags:
Sanofi, dividends, Merck, Pfizer
4 Biopharma Swing Trades For The Mid Term - 3 Week Report Card
Seeking Alpha
Fri, 03/23/12 - 12:20 pm
Tags:
Ariad Pharmaceuticals, Sanofi, Spectrum Pharmaceuticals, Questcor, Antares
Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin
Bloomberg
Fri, 03/23/12 - 11:30 am
Tags:
lawsuits, Sanofi, Roche, Rituxan, Avastin, Genentech, Biogen Idec
The Best High Dividend Pharma Stocks
Motley Fool
Wed, 03/21/12 - 10:05 am
Tags:
dividends, AstraZeneca, Pfizer, Sanofi, Merck, Eli Lilly, GSK
Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
Seeking Alpha
Wed, 03/21/12 - 10:01 am
Tags:
FDA, Pfizer, Sanofi, Shire, taliglucerase alfa, Gaucher disease, Protalix BioTherapeutics
9 Pharma Buys for a Healthy Portfolio
Investor Place
Sun, 03/18/12 - 11:26 am
Tags:
Novo Nordisk, Valeant Pharmaceuticals, GSK, Abbott Laboratories, Eli Lilly, JNJ, Pfizer, Merck, Sanofi
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
Yahoo
Fri, 03/16/12 - 11:27 am
Tags:
Sanofi, Pluromed, M&A
A Drug Class Back From the Dead?
Motley Fool
Wed, 03/14/12 - 09:42 am
Tags:
Pfizer, Regeneron, JNJ, Sanofi, AstraZeneca, FDA, NGF blockers
Merck: Strong Pipeline For Dividend Growth
Seeking Alpha
Fri, 03/9/12 - 04:20 pm
Tags:
Merck, dividends, GSK, Bristol-Myers Squibb, Pfizer, Sanofi
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Tags:
Pfizer, JNJ, FDA, joint failure, painkillers, fulranumab, Sanofi, Regeneron, tanezumab, REGN475/SAR164877
Sanofi CEO interested in emerging-market deals
Reuters
Wed, 03/7/12 - 10:12 am
Tags:
Sanofi, Pharma CEOs, emerging markets, Chris Viehbacher
February Healthcare Sector Dogs Sit Up
Seeking Alpha
Tue, 03/6/12 - 11:21 am
Tags:
AstraZeneca, GSK, Eli Lilly, Merck, NeoStem, Sanofi, PDL Biopharma
Most Popular Drug Manufacturers among Hedge Funds
Motley Fool
Mon, 03/5/12 - 06:15 pm
Tags:
Pfizer, hedge funds, Sanofi, JNJ, Merck, Abbott Laboratories, Eli Lilly, Bristol-Myers Squibb
Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Sat, 03/3/12 - 11:24 am
Tags:
Isis Pharmaceuticals, Kynamro, Genzyme, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.